Wang Huimin, Li Dianzhen, Wang Chunyan, Wang Xiaobin, Yu Mingxin, Zhang Xin, Li Liankun, Zeng Qingdong, Long Zaiqiu, Zheng Wei, Liu Guangcong, Wang Danbo
Department of Gynecology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Department of Epidemiology, Liaoning Cancer Hospital & Cancer Hospital of China Medical University, Shenyang, China.
Ann Transl Med. 2022 Jan;10(2):124. doi: 10.21037/atm-21-6450.
To investigate the survival outcomes of abdominal radical hysterectomy (ARH), laparoscopic radical hysterectomy (LRH), and vaginal-assisted laparoscopic radical hysterectomy (VALRH) in the treatment of cervical cancer patients.
This was a retrospective study. We collected the clinical data of 654 patients with cervical cancer (406 ARH, 172 LRH, and 76 VALRH), then compared the effects of different surgical methods on recurrence and survival.
Total overall survival (OS) were no significant differences in three groups (P>0.05). Total disease-free survival (DFS) was significantly higher in ARH group than in LRH group [hazard ratio (HR) =2.8, 95% confidence interval (CI): 1.199-3.607, P=0.004]; however, there were no significant differences between the VALRH (94.7%) and ARH (93.3%) groups. Subgroup stratification analysis showed that the overall recurrence rate in LRH group was significantly higher than that of the ARH groups for patients with a tumor size from ≥2 to <4 cm, negative postoperative lymph nodes, and no postoperative adjuvant therapy (all P<0.05). However, in the subgroup with tumor sizes of ≥2, <4, and ≥4 cm, no matter whether the lymph nodes were positive or not, and those with no postoperative supplementary adjuvant therapy, LRH was associated with a significantly higher local pelvic recurrence rate than ARH (all P<0.05). No significant differences between VALRH and ARH in any of the subgroup analyses (all P>0.05). A Cox analysis indicated that LRH increased the risk of overall and local pelvic recurrence after surgery compared with ARH (HR =2.338, 95% CI: 1.186-4.661, P=0.014; HR =10.313, 95% CI: 2.839-37.460, P<0.001); however, no significant difference between VALRH and ARH (all P>0.05). Sensitivity analysis of surgeons did not change the conclusions.
Our analyses showed that the local pelvic recurrence rates and overall recurrence rates of LRH were significantly higher than ARH. VALRH could avoid tumor intraperitoneal exposure and achieve the same tumor prognosis as open surgery. By improving the standardization of minimally invasive surgery for early cervical cancer and paying close attention to the tumor-free concept, minimally invasive radical hysterectomy may achieve the same tumor outcome as open surgery.
探讨腹式根治性子宫切除术(ARH)、腹腔镜根治性子宫切除术(LRH)及阴道辅助腹腔镜根治性子宫切除术(VALRH)治疗宫颈癌患者的生存结局。
这是一项回顾性研究。我们收集了654例宫颈癌患者的临床资料(406例行ARH,172例行LRH,76例行VALRH),然后比较不同手术方法对复发和生存的影响。
三组的总总生存期(OS)无显著差异(P>0.05)。ARH组的总无病生存期(DFS)显著高于LRH组[风险比(HR)=2.8,95%置信区间(CI):1.199 - 3.607,P = 0.004];然而,VALRH组(94.7%)和ARH组(93.3%)之间无显著差异。亚组分层分析显示,对于肿瘤大小≥2至<4 cm、术后淋巴结阴性且无术后辅助治疗的患者,LRH组的总体复发率显著高于ARH组(所有P<0.05)。然而,在肿瘤大小≥2、<4和≥4 cm的亚组中,无论淋巴结是否阳性以及无术后补充辅助治疗的患者,LRH组的局部盆腔复发率均显著高于ARH组(所有P<0.05)。在任何亚组分析中,VALRH组和ARH组之间均无显著差异(所有P>0.05)。Cox分析表明,与ARH相比,LRH增加了术后总体和局部盆腔复发的风险(HR = 2.338,95% CI:1.186 - 4.661,P = 0.014;HR = 10.313,95% CI:2.839 - 37.460,P<0.001);然而,VALRH组和ARH组之间无显著差异(所有P>0.05)。外科医生的敏感性分析未改变结论。
我们的分析表明,LRH的局部盆腔复发率和总体复发率显著高于ARH。VALRH可避免肿瘤腹腔内暴露,并实现与开放手术相同的肿瘤预后。通过提高早期宫颈癌微创手术的标准化并密切关注无瘤概念,微创根治性子宫切除术可能实现与开放手术相同的肿瘤治疗效果。